|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-11-8
|
|
pubmed:abstractText |
Vesnarinone, a positive inotropic and immunomodulatory agent, diminishes nitric oxide (NO) levels by suppressing the induction of inducible NO synthase (iNOS) expressed in cytokine-stimulated macrophages and cardiomyocytes. We examined whether vesnarinone exerts inhibitory effects on the progression of myocardial damage in experimental autoimmune myocarditis in rats through suppression of iNOS.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0008-6363
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
389-97
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10536669-Analysis of Variance,
pubmed-meshheading:10536669-Animals,
pubmed-meshheading:10536669-Autoimmune Diseases,
pubmed-meshheading:10536669-Biological Markers,
pubmed-meshheading:10536669-Blotting, Northern,
pubmed-meshheading:10536669-Female,
pubmed-meshheading:10536669-Interleukin-1,
pubmed-meshheading:10536669-Myocarditis,
pubmed-meshheading:10536669-Myocardium,
pubmed-meshheading:10536669-Nitric Oxide,
pubmed-meshheading:10536669-Nitric Oxide Synthase,
pubmed-meshheading:10536669-Nitric Oxide Synthase Type II,
pubmed-meshheading:10536669-Quinolines,
pubmed-meshheading:10536669-Rats,
pubmed-meshheading:10536669-Rats, Inbred Lew,
pubmed-meshheading:10536669-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Inhibitory effects of vesnarinone in the progression of myocardial damage in experimental autoimmune myocarditis in rats.
|
|
pubmed:affiliation |
Department of Pathology, Tokyo Women's Medical University School of Medicine, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
